Manufacturing and Production

Showing 15 posts of 5867 posts found.

Booklet labels or Just-In-Time labelling: A question of standards

September 7, 2017 Business Services, Manufacturing and Production Faubel, Labelling, packaging

Pharmaceutical companies are multiplying their efforts to establish just-in-time labeling. For Anthony Morrow, Business Development Manager Northern Europe at Faubel, …

High demands: Requirements on the labelling of pharmaceutical products are growing continuously

September 7, 2017 Business Services, Manufacturing and Production Faubel, Labelling

There are numerous criteria to be met by label manufacturers. In this context, topics such as patient compliance and smart …
spotleukaemia

Spotting Leukaemia

September 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, leukaemia, pharma, pharmaceutical

Leukaemia is a household name, but how much do we really understand about it? Not enough, says Bethany Torr, Campaigns …
narasimhan_2

Novartis exec designated as new CEO after Jimenez announces retirement

September 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, a, joe jimenez, phar, pharma, pharmaceuticals

Novartis has announced that its Chief Executive, Joe Jimenez, is set to retire next year. In his place, Vasant Narasimhan …
mr058666-web

Merck KGaA commits to continued partnership with Ugandan Government

September 5, 2017 Manufacturing and Production, Medical Communications Merck, infertility, life sciences, pharma, pharmaceuticals, uganda

Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit …
pfizer-building-logo1web

Pfizer’s drug back on the market after proving safety

September 5, 2017 Manufacturing and Production, Sales and Marketing Mylotarg, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) …
novartis_side_building

Novartis celebrates success of Gilenya in paediatric multiple sclerosis

September 5, 2017 Manufacturing and Production, Research and Development MS, Novartis, gilenya, health, multiple sclerosis, pharma, pharmaceuticals

Novartis has announced results of its Phase 3 study investigating the safety and efficacy of Gilenya (fingolimod) , finding that …
merck_kgaa_pyramid_use_with_credit

Merck KGaA to streamline business with $1bn healthcare sale

September 5, 2017 Manufacturing and Production, Sales and Marketing GSK, Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA has revealed that it is looking to sell its consumer healthcare business, in order to refocus the business …
asthma

Asthma drugs reduce Parkinson’s risk by 50%, decade-long study finds

September 5, 2017 Manufacturing and Production, Research and Development Parkinson's, Parkinson's disease, asthma, pharma, pharmaceuticals, salbutamol

A study from the Department of Global Public Health and Primary Care at the University of Bergen (UiB) in Norway …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Trump, drugs, health, life sciences, medicine, pharma, pharmaceutical, top ten

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

R&D tax credits: A novel approach to supply chain funding

September 1, 2017 Manufacturing and Production, Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, tax credits

Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …
governance_guenterpeter

EVP of Diabetes decamps from Sanofi to become Almirall CEO

August 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …
The Gateway to Local Adoption Series

Latest content